May 14, 2020

A new combination treatment targeting “cancer stem cells” may overcome drug resistance in blood cancers

Building on a BC Cancer discovery from decades past, a new combination treatment has shown promise to overcome drug resistance and relapse in people with chronic myeloid leukemia. 

Building off the discovery of an enzyme called integrin-linked kinase (ILK) made by BC Cancer distinguished scientist Dr. Shoukat Dedhar 24 years ago, BC Cancer’s Drs. Xiaoyan Jiang and Shoukat Dedhar have made a significant advancement in understanding the role of this enzyme in blood cancers. 

Back to top